LDOS

Analyst Note: Leidos Holdings, Inc. (LDOS)

Date: 2026-06-13 Current Price: $107.12

1. Structural Readiness

State: Forming Conservative Entry: — (Awaiting confirmed breakout close) Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone; requires thesis conviction) Breakout Level: — (Not yet established; requires price action to clear the current consolidation range). Current Price: $107.12 Extension: — (No extension data provided; price is currently within the consolidation range). ATR Current: 3.9% (Productive / Within historical sweet spot for volatility).

2. Thesis Layer

Primary Secular Thesis: Defense Modernization (C4ISR / Sensors / EW). Role & Directness: Leidos is a direct, high-conviction beneficiary. The company has transitioned from a general IT integrator to a "key disruptor" capable of reliable scale production.

• Evidence: Management explicitly stated they have earned over $9 billion of awards for their Defense Tech business in the last 15 months alone, with a clear path to another $8 billion in the next 12-month pipeline.
• Specific Exposure: The company is capitalizing on technological investments to deliver mission-critical solutions to the Department of War (DoW) and Intelligence Community. This includes serial production of the ALPS product under a $2.2 billion ABADS-MD contract, with production runs of "thousands of these products" expected this decade.

Secondary Secular Thesis: Cybersecurity (Security Services / MSSP). Role & Directness: Leidos serves as a tier-second-order beneficiary, leveraging its "Digital Modernization and Cyber" pillar to provide robust cybersecurity defenses and intelligence analysis.

• Evidence: The company is developing an AI-driven tool for the "My Service Treatment Record" pilot program, automating medical record transfers for the DoW and VA, demonstrating deep integration into government digital infrastructure.

Combined Exposure: The name rides two structural waves: the immediate, high-velocity demand for defense hardware/software production (C4ISR) and the long-term, sticky demand for digital modernization and cybersecurity services. The convergence of these themes suggests a robust revenue floor with significant upside from the new defense tech awards.

3. The Business

Business Model: Leidos operates as a technology services and systems integrator, primarily serving the U.S. government. The model relies on long-term contracts (RPO) and recurring service revenue, with a heavy emphasis on mission-critical solutions. Industry: Technology / Defense Services. Operations:

• Revenue Mix: As of the fiscal year ended January 2, 2026, 87% of revenues were derived from U.S. government contracts (either prime or subcontractor).
• Segment Breakdown:
• National Security & Digital: Represents 44% of total revenues (fiscal 2025). This segment covers air, land, sea, space, and cyberspace domains, including command and control platforms and data analytics.
• Health & Civil: Represents 30% of total revenues. The Civil segment serves the FAA (e.g., ERAM, ATOP programs), while the Health segment provides managed healthcare and digital transformation services.
• Recent Performance:
• Q1 2026 (ended April 3, 2026): Revenue was $4.40 billion, beating estimates by 2.8%. Non-GAAP EPS was $3.13, beating estimates by 8.7%.
• Bookings: Net bookings for the quarter were $3.3 billion, a significant increase from $2.1 billion in the prior year quarter.
• Backlog: As of April 3, 2026, the company held $19 billion in Remaining Performance Obligations (RPO). Management expects to recognize 62% of this over the next 12 months and 82% over the next 24 months.
• Strategic Moves: The company completed the acquisition of Savanna Industries, Inc. ("Kudu Dynamics") in fiscal 2025, expanding its capabilities in autonomous systems and defense tech.

4. Archetype and Conviction

Archetype: Defensive Operator / Growth Leader. Fit: Leidos fits the "Defensive Operator" archetype due to its high revenue visibility (87% government-backed) and stable cash flows, while simultaneously acting as a "Growth Leader" in the defense tech sector due to the $9B+ recent awards and the shift toward serial production of hardware (ALPS). Valuation Context:

• Forward Consensus EPS: FY1 (2026) is $11.84; FY2 (2027) is $12.33.
• Guidance: Management raised 2026 guidance for revenue by $500 million, non-GAAP diluted EPS by $0.05, and operating cash flow by $50 million.
• Dividend: A quarterly cash dividend of $0.43 per share was declared, payable June 30, 2026.

Conviction Stack:

• Thesis Strength: High. The company is directly positioned in the "Defense Modernization" wave with tangible, large-scale awards ($9B+).
• Evidence Quality: Strong. Recent earnings (May 5, 2026) provided specific, quantified guidance and booking data that exceeded consensus.
• Structural Quality: The RPO of $19B provides a multi-year revenue runway. The acquisition of Savanna Industries validates the strategic pivot to high-tech defense manufacturing.
• Setup Readiness: Moderate. The setup is "Forming." The price is holding above support, but the breakout has not fired. The ATR of 3.9% indicates productive volatility, suitable for position sizing but not yet a confirmation signal.
• Rerating Potential: Moderate to High. The market may re-rate the company from a "services integrator" to a "defense tech manufacturer" as the ALPS serial production scales and the $10B refreshed order pipeline materializes.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Fundamental: A significant reduction in the $19B RPO backlog or a failure to execute the $10B refreshed order pipeline target.
• Operational: Delays in the serial production of the ALPS product or the My Service Treatment Record pilot.

Strengtheners:

• Technical: A confirmed breakout close above the current consolidation range (resistance).
• Fundamental: Further upward revisions to 2026 guidance or the announcement of additional multi-billion dollar awards in the Defense Tech sector.
• Operational: Confirmation of "thousands of units" in production runs for ALPS.

Gaps in Evidence:

• Specific Profit Margins: While revenue and EPS are provided, specific margin expansion data for the new Defense Tech segment (vs. legacy services) is not explicitly detailed in the provided evidence, though implied by the "disruptor" narrative.
• Commercial Exposure: The evidence heavily emphasizes government contracts (87%). The specific growth trajectory and margin profile of the commercial segment (13%) are less detailed.
• Integration Risks: While the Savanna acquisition is noted, the specific impact on near-term margins or integration costs is not quantified in the provided text.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Management raised 2026 guidance by $500M revenue and $0.05 EPS; $9B in Defense Tech awards earned in last 15 months with $8B pipeline; $19B RPO backlog with 62% recognition expected in next 12 months. Key risks: Technical setup is forming, not confirmed; heavy reliance on U.S. government contracts (87% of revenue); potential execution risk on serial production of ALPS; government shutdown or budget delays. Sizing hint: Position size should reflect the "forming" status; allocate based on thesis conviction but maintain flexibility to add on confirmed breakout. Expected path: Management expects to recognize 62% of RPO in 12 months; Defense Tech segment should drive revenue growth as ALPS enters serial production; dividend provides downside support. Expected horizon: 12 to 24 months for the RPO recognition and production scaling to fully impact financials.